Attention to the interests of society

Jiangsu Harvers Biotech Co., Ltd. started in 2004 and is an innovative platform company based on synthetic biology technology for bio-manufacturing. The company's core team has a long-term background in biological fermentation and biotechnology. The company was rated as a national high-tech enterprise in 2021. The company has mastered the core technology of synthetic biology and has 18 patents in the United States and China.

Harvers Biotech is committed to using excellent chassis microorganisms, using synthetic biology technology and methods to design, develop, and manufacture natural compounds and new biological materials. Its products are widely used in medicine, health products, feed additives, food, cosmetics and other industries.

Harvers Biotech products are manufactured by microbiological methods, and have established R&D centers and manufacturing systems that comply with USP, GMP, HACCP, ISO9001 and other standards. The manufacturing system plans to have a total volume of 3,500 cubic meters of fermentation tanks and produce 30,000 tons of high value-added biological products. The total sales are expected to be around 2 billion RMB.

"Wide sea diving, sky high the birds to fly". Harvers Biotech is committed to becoming a leader in the field of synthetic biology, producing low-cost, high-quality, and large-volume biological products to serve downstream companies; at the same time, it uses efficient, green and environmentally friendly technical routes to meet the requirements of the "low-carbon era".